Macy Burkhart|
Payton Greenlee joined the MJ team as a risk management intern. Following graduation, she joined MJ full-time as an associate in our Risk Management + Commercial Insurance department and quickly progressed to the role of risk transfer specialist. She creates comprehensive risk financing and transfer strategies. She is adept at communicating the intricacies of the plan suggestions, and her attention and care for her clients makes her a vital asset to her team.
Payton’s journey with MJ began when she interned in our Risk Management + Commercial Insurance department while pursuing her studies at Butler University. This experience enabled her to gain valuable insights into the inner workings of various departments, including analytics, risk services, risk transfer, sales, claims, and advocacy.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More